3438-49-1

Basic information

• Product Name: 4-T-BUTYL-6-HYDROXYPYRIMIDINE
• Synonyms: 6-TERT-BUTYLPYRIMIDIN-4-OL;4-T-BUTYL-6-HYDROXYPYRIMIDINE;6-(tert-butyl)pyrimidin-4(3H)-one
• CAS NO: 3438-49-1
• Molecular Formula: C8H12N2O
• Molecular Weight: 152.19
• Mol File: 3438-49-1.mol
• Article Data: 9

Chemical Properties

• Melting Point: 210-211 °C
• Boiling Point: 227.2±23.0 °C(Predicted)
• Appearance: /
• Density: 1.07±0.1 g/cm3(Predicted)
• PKA: 9.51±0.40(Predicted)
• CAS DataBase Reference: 4-T-BUTYL-6-HYDROXYPYRIMIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-T-BUTYL-6-HYDROXYPYRIMIDINE(3438-49-1)
• EPA Substance Registry System: 4-T-BUTYL-6-HYDROXYPYRIMIDINE(3438-49-1)

Safety Data

• Hazardous Substances Data: 3438-49-1(Hazardous Substances Data)

Upstream product

• 3435-27-6 6-tert-butylpyrimidin-4-ylamine 
• 55107-14-7 Methyl 4,4-dimethyl-3-oxopentanoate 
• 3473-63-0 formamidine acetic acid 
• 66698-66-6 6-tert-butyl-2-mercapto-pyrimidin-4-ol 
• 3438-47-9 4-tert-butyl-pyrimidine 
• 17094-34-7 ethyl pivaloylacetate 
• 17356-08-0 thiourea 

Downstream Products

• 3435-24-3 4-tert-butyl-6-chloro-pyrimidine 
• 19136-36-8 6-Brom-4-t-butyl-pyrimidin 
• 1443732-45-3 4-tert-butyl-6-(3,5-dimethylphenyl)pyrimidine 

Relevant articles and documents

Organometallic complex, light-emitting element, light-emitting device, electronic appliance, and lighting device

A light-emitting element including a phosphorescent organometallic complex is provided. The organometallic complex emits phosphorescence in the yellow green to orange wavelength range and has high emission efficiency and high reliability. Thus, the organo

Organometallic Complex, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device

As a novel substance having a novel skeleton, an organometallic complex with high emission efficiency which achieves improved color purity by a reduction of half width of an emission spectrum is provided. One embodiment of the present invention is an orga

INDOLE AND AZAINDOLE MODULATORS OF THE ALPHA 7 NACHR

This invention relates to modulation of the α7 nicotinic acetylcholine receptor (nAChR) by a compound of formula (I) or a pharmaceutically acceptable salt thereof.